Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients

World J Gastroenterol. 2017 Dec 28;23(48):8526-8532. doi: 10.3748/wjg.v23.i48.8526.

Abstract

Aim: To determine the prevalence, characteristics and clinical course of pancreatic cystic neoplasms (PCNs) in liver transplantation (LT) recipients.

Methods: We retrospectively studied consecutive patients who underwent LT between January 1998 to April 2016. Clinical and laboratory data were obtained from patient medical records. Imaging findings on computed tomography and magnetic resonance cholangiopancreatography were reviewed by two radiologists.

Results: During the study period, 872 patients underwent cadaveric LT. Pancreatic cysts were identified in 53/872 (6.1%) and 31/53 (58.5%) were PCNs [28 intraductal papillary mucinous neoplasm (IPMN), 2 mucinous cystic neoplasm (MCN), 1 serous cystadenoma]. Patients with PCNs exhibited less male predominance (55% vs 73%, P = 0.03) compared to patients without pancreatic cysts. Thirteen patients (42%) were diagnosed with PCN pre-LT while 18 patients (58%) developed PCN post-LT. The median size of PCNs was 13mm [interquartile range (IQR) 10-20 mm]. All IPMNs were side-branch type. Most PCNs were found in the head and body of pancreas (37% each), followed by the tail (25%). Five patients underwent further evaluation with endoscopic ultrasound. Progress imaging was performed on 81% of patients. PCNs remained stable in size and number in all but 2 patients. During a median follow up of 39 mo (IQR 26-58 mo), the 2 (6%) patients with MCN underwent pancreatectomy. No PCN patient developed pancreatic adenocarcinoma, while 5 died from illnesses unrelated to the PCN. Among patients without PCN, 1/841 (0.1%) developed pancreatic adenocarcinoma.

Conclusion: The prevalence of PCNs in LT recipients was similar to the general population (3.6%, 31/872). Side-branch IPMNs do not appear to have accelerated malignant potential in post-LT patients, indicating the current surveillance guidelines are applicable to this group.

Keywords: Immunosuppression; Intraductal papillary mucinous neoplasm; Liver transplantation; Mucinous cystic neoplasm; Pancreatic adenocarcinoma; Pancreatic cystic neoplasm.

MeSH terms

  • Adenocarcinoma, Mucinous / diagnostic imaging
  • Adenocarcinoma, Mucinous / epidemiology*
  • Adenocarcinoma, Mucinous / surgery
  • Aged
  • Australia / epidemiology
  • Carcinoma, Hepatocellular / diagnostic imaging
  • Carcinoma, Pancreatic Ductal / diagnostic imaging
  • Carcinoma, Pancreatic Ductal / epidemiology*
  • Carcinoma, Pancreatic Ductal / surgery
  • Early Detection of Cancer / standards
  • End Stage Liver Disease / surgery*
  • Endosonography
  • Female
  • Follow-Up Studies
  • Humans
  • Incidental Findings
  • Liver Transplantation*
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pancreatectomy
  • Pancreatic Cyst / diagnostic imaging
  • Pancreatic Cyst / epidemiology*
  • Pancreatic Cyst / surgery
  • Pancreatic Neoplasms / diagnostic imaging
  • Pancreatic Neoplasms / epidemiology*
  • Pancreatic Neoplasms / surgery
  • Practice Guidelines as Topic
  • Prevalence
  • Retrospective Studies
  • Sex Factors
  • Tomography, X-Ray Computed